Health News Releases

  • Today December 21
February 02, 2018 18:40
PharmAbcine Enters Collaboration with MSD Focused on Clinical Evaluation of TTAC-0001 in Combination with KEYTRUDA® (pembrolizumab) in Recurrent Glioblastoma and Breast Cancer
PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announces it has entered into a collaborative agreement with MSD (tradename o
February 02, 2018 16:55
World Health Organization Director-General to Deliver Keynote at Patient Safety Summit
Global leaders, patient safety experts, hospital and medical technology CEOs and patient advocates will gather to address the challenges that cause medical errors and preventable deaths in hospitals w
January 31, 2018 17:10
Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAK-426, Takeda’s purified, inactiv
January 26, 2018 16:00
Ferring Announces Recipients of Innovation Grants Program 2017-2018
Ferring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in San Diego. This global program
January 24, 2018 15:55
European Commission Approves ADCETRIS® (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma after One Prior Systemic Therapy- Providing an Innovative Treatment Option to Patients
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC) extended the current conditional marketing authorization of ADCETRIS® (brentuximab vedotin) and appr
January 24, 2018 11:25
Takeda Recognized as a Global 100 Most Sustainable Corporation for Third Consecutive Year
Takeda Pharmaceutical Company Limited [TOKYO:4502], (“Takeda”) is proud to be named by Corporate Knights as one of the 2018 Global 100 Most Sustainable Corporations in the World (Global 100) for the t
January 23, 2018 11:35
Octapharma: Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A
Octapharma is delighted to announce the publication of final data from a Good Clinical Practice (GCP) trial in PUPs in the internationally renowned medical journal Haemophilia. The study assessed the
January 23, 2018 11:05
New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the annual meeting of the Society for Technology in Anesthesia (STA) in Miami, Florida. In the study, researchers at the
January 23, 2018 09:25
Ferring enters into worldwide OmniAb® platform license agreement with Ligand
Ferring Pharmaceuticals announced today that it has entered into a worldwide license agreement with Ligand Pharmaceuticals to use Ligand’s OmniAb platform® to discover new human monoclonal antibodies
January 18, 2018 16:00
AMR Industry Alliance: Report Shows Life Sciences Industry Alliance is Taking Action to Curb Antimicrobial Resistance, with More to Come
Today, the AMR Industry Alliance launches its first report that shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR). The Alliance br
January 18, 2018 13:40
Premas, IncellDx Ink India Distribution Agreement
Premas Life Sciences Pvt., Ltd. and IncellDx, Inc. announced today they have signed an exclusive distribution agreement. The commercial partnership brings the power of cell by cell multiplex diagnosti
January 18, 2018 13:30
President Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology Summit
For the 6th year in a row, President Bill Clinton, the Founder of the Clinton Foundation and 42nd President of the United States, will deliver keynote remarks at the 6th Annual World Patient Safety, S
January 12, 2018 14:30
Herbalife Nutrition Enhances Personalized Nutrition Program with Launch of Gene Start in South Korea
With the goal of helping people live healthier and happier, Herbalife Nutrition today launched Gene Start in South Korea, the first of its markets in the world to introduce an innovative healthcare se
January 11, 2018 19:25
Ferring and the Chinese Academy of Sciences Collaborate to Advance Research in Reproductive Medicine
Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) today announced a long-term collaboration to advance basic and translational research in reproductive medicine through the development
January 11, 2018 17:30
Parrish Medical Center Awarded Patient Safety Movement’s First 5-Star Hospital Ranking
The Patient Safety Movement Foundation (PSMF) today awarded Florida-based Parrish Medical Center with the first-ever Patient Safety Five-Star Hospital ranking for implementing all 13 Actionable Patien
January 11, 2018 17:20
AHF Strongly Condemns Violence Against Rohingya in Rakhine State, Myanmar
AIDS Healthcare Foundation (AHF) strongly condemns violence against the Rohingya Muslims in Myanmar’s Rakhine State. As a global humanitarian organization, with operations in 39 countries, including M
January 09, 2018 17:15
Save Lives, Fish with President Carter and Patient Safety Movement Foundation
For the fourth year in a row, former President Jimmy Carter and First Lady Rosalynn Carter are supporting the Patient Safety Movement Foundation (PSMF) and demonstrating their commitment to ZERO Preve
January 09, 2018 11:35
Synapse Biomedical Inc. Receives CE Approval for TransAeris, the First Medical Device Approved for the Treatment of Ventilator Induced Diaphragm Dysfunction (VIDD)
Synapse Biomedical (www.synapsebiomedical.com), an innovator in neurostimulation and manufacturer of the NeuRx Diaphragm Pacing System®, announced today, the CE Mark approval for the TransAeris™ Syste
SELVAS AI will exhibit “Selvy Checkup,” the world's first AI disease prediction service, at CES 201
January 09, 2018 08:00
SELVAS AI to be in spotlight at CES 2018 for ‘Selvy Checkup’, World’s First AI Disease Prediction Service
SELVAS AI, an artificial intelligence company, will participate in CES (Consumer Electronics Show) 2018, the world’s largest consumer technology event in Las Vegas, Nevada, USA, from January 9 to 12.
GE, Roche Enter Partnership to develop an industry-first digital platform, using advanced analytics
January 08, 2018 16:55
GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment
GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointly develop and co-market digital clinical decision support solutions. The partnership
January 08, 2018 10:20
ZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs Monitor
ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today the receipt of a sole source contract from the Defense Logisti
January 04, 2018 13:10
HeartSciences, a Fierce Innovation Award Finalist, Will Present at BioTech Showcase Events in San Francisco on January 9 and 10, 2018
HeartSciences, a medical device company recently selected as a finalist for the Fierce Innovation Awards in the Digital Health Solution category, will be presenting in San Francisco at the BioTech Sho
January 04, 2018 09:15
Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€
Boehringer Ingelheim today announced an increase in funding for its corporate venture fund, known as the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million. The additional funds wil
January 03, 2018 10:15
Masimo Announces CE Marking and Release of Oxygen Reserve Index™ rainbow Lite Sensors
Masimo (NASDAQ: MASI) announced today the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ (ORi™) and RPVi™, an improved PVi® that al
Denis DELVAL, CEO of LFB S.A.
December 22, 2017 08:57
Denis DELVAL is Appointed CEO of LFB SA
On December 20th, a decree from the President of France was published in Le Journal Officiel* appointing Denis DELVAL CEO of LFB S.A. This decree follows the General Meeting of LFB SA and the meeting
25 per page50 per page75 per page100 per page